1Frishman WH,Ismail AA.Role of infection in astherosclerosis and coronary artery disease:a new therapeutic target?[J].Cardiol Rew,2002,10(4):199-210.
2De Backer J,Mark R,De Bacquer D,et al.Parameters of inflammation and infection in a community based case-control study of coronary heart disease[J].Atherosclerosis,2002,160(2):457-463.
3Prasad A,Zhu J,Halcox JP,et al.Predisposition to atherosclerosis by infections:role endothelial dysfunction[J].Circulation,2002,106(2):184-190.
4Mendall MA,Goggin PM,Molineaux N,et al.Relation of Helicobacter pylori infection and coronary heart disease[J].Br Heart J,1994,71(2):437-439.
5Patel P,Mendall MA,Carington D,et al.Association of Helicobacter pylori and pneumoniae infections with coronary heart disease and chlamydia cardiovascular risk factors[J].BMJ,1995,311(7 007):711-714.
6TOUSOULIS D, DAVIES GJ, ASIMAKOPOULOS G, et al. Vascular cell adhesion molecule-1 and intercellular ad- hesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X) [J]. Clin Car- diol, 2001, 24(4):301-304.
7OSHIMA T, OZONO R, YANO Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects [J]. J Am Coil Cardiol, 2005, 45(8):1219-1222.
8GEN R, DEMIR M, ATASEVEN H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation [J].South Med J, 2010, 103 (3): 190-196.
9GUNJI T, MATSUHASHI N, SATO H, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population [J]. Am J Gastroen- terol, 2008, 103(12):3005-3010.
